CAPOX

CAPOX is a combination chemotherapy treatment used primarily for colorectal cancer. It includes two medications: capecitabine (brand name Xeloda), an oral drug that turns into chemotherapy inside the body, and oxaliplatin, administered intravenously. Together, they work by damaging cancer cells' DNA, preventing them from dividing and growing. This combination aims to improve treatment effectiveness while minimizing side effects compared to other regimens. CAPOX is often given in cycles over several months, depending on the patient's specific condition, and is a standard approach in managing colorectal cancer.